住院环境下负责任抗生素使用的质量指标:系统综述及国际多学科共识流程
本研究为DRIVE-AB项目的一部分,旨在制定住院环境下负责任抗生素使用的通用质量指标(QIs)。采用RAND改良德尔菲法,先通过系统综述识别QIs,再由25名国际多学科利益相关者经两轮问卷和共识会议评估,最终共识选出51项QIs。结论认为该逐步方法结合文献证据与利益相关者意见,形成了可全球用于评估抗生素使用质量的住院通用QIs。
要点
- 系统综述检索到70项潜在通用QIs,最终共识选出51项。
- 相关性最高的QIs包括:抗生素治疗开始时应在病历中记录抗生素计划。
- 相关性最高的QIs还包括:应记录细菌药敏试验结果、当地指南应基于国家指南并适配当地耐药模式、医疗机构应设有抗生素管理项目、处方抗生素时应考虑过敏状态。
核心结论
- 结合文献证据与利益相关者意见的系统逐步方法,就住院通用QIs达成国际多学科共识,可用于全球评估抗生素使用质量。
研究设计与样本
- 采用RAND改良德尔菲法,先通过系统综述识别QIs,并对相关组织网站进行补充检索。
- 去重后将疾病和患者特异性QIs合并为通用指标,由25名国际多学科利益相关者通过两轮问卷和一次中间共识会议评估相关性。
主要发现
- 系统综述检索到70项潜在通用QIs。
- 由25名来自医学界、公共卫生、患者、抗生素研发、监管机构和政府的国际利益相关者评估后,最终共识选出51项QIs。
关键数值与推荐
- 相关性最高的QIs包括:抗生素治疗开始时应在病历中记录抗生素计划。
- 相关性最高的QIs包括:应在病历中记录细菌药敏试验结果。
- 相关性最高的QIs包括:当地指南应与国家指南一致,但应根据当地耐药模式进行调整。
- 相关性最高的QIs包括:医疗机构应设有抗生素管理项目。
- 相关性最高的QIs包括:处方抗生素时应考虑过敏状态。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study was conducted as part of the Driving Reinvestment in Research and Development and Responsible Antibiotic Use (DRIVE-AB) project and aimed to develop generic quality indicators (QIs) for responsible antibiotic use in the inpatient setting. METHODS: A RAND-modified Delphi method was applied. First, QIs were identified by a systematic review. A complementary search was performed on web sites of relevant organizations. Duplicates were removed and disease and patient-specific QIs were combined into generic indicators. The relevance of these QIs was appraised by a multidisciplinary international stakeholder panel through two questionnaires and an in-between consensus meeting. RESULTS: The systematic review retrieved 70 potential generic QIs. The QIs were appraised by 25 international stakeholders with diverse backgrounds (medical community, public health, patients, antibiotic research and development, regulators, governments). Ultimately, 51 QIs were selected in consensus. QIs with the highest relevance score included: (i) an antibiotic plan should be documented in the medical record at the start of the antibiotic treatment; (ii) the results of bacteriological susceptibility testing should be documented in the medical record; (iii) the local guidelines should correspond to the national guidelines but should be adapted based on local resistance patterns; (iv) an antibiotic stewardship programme should be in place at the healthcare facility; and (v) allergy status should be taken into account when antibiotics are prescribed. CONCLUSIONS: This systematic and stepwise method combining evidence from literature and stakeholder opinion led to multidisciplinary international consensus on generic inpatient QIs that can be used globally to assess the quality of antibiotic use.
引用
- Monnier AA, Schouten J, Le Maréchal M, et al. Quality indicators for responsible antibiotic use in the inpatient setting: a systematic review followed by an international multidisciplinary consensus procedure. J Antimicrob Chemother. 2018. PMID: 29878221. doi:10.1093/jac/dky116
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。